본문 바로가기
KERD
논문KCI 등재

The Effect of Adding Kami-guibi-tang to Acetylcholinesterase Inhibitor Treatment on the Cognitive Function of Mild Alzheimer's Disease Patients: Study Protocol of a Randomized, Placebo-Controlled, Double-Blind Pilot Trial

장건호|이창우|신희연|김정화|박성욱|고창남|박정미|김하리|양승보
대한한방내과학회 (The Society Of Korean Oriental Internal Medicine)|2020.06|대한한방내과학회지 (The Journal of Korean Oriental Internal Medicine)|제41권 제3호|pp. 326-338|DOI https://doi.org/10.22246/jikm.2020.41.3.326

2

조회

0

다운로드

0

인용

0

참고문헌

키워드

mild Alzheimer's diseaseherbal medicinemagnetic resonance imaging (MRI)Kami-guibi-tangSeoul neuropsychological screening battery (SNSB)
주제분류한의학

초록

Background: Alzheimer's disease (AD) is a chronic neurodegenerative disease that causes disorientation, mood swings, problems with language, and difficulty remembering recent events. Acetylcholinesterase inhibitors (AchEIs) and memantine have been used to slow the course of the disease, but they can neither modify its progression nor prevent disease onset. Previous studies have suggested that Kami-guibi-tang (KGT) could be beneficial for supporting cognitive function in AD patients, but few clinical trials have been published. This pilot study aimed to evaluate the effect of KGT in improving cognitive function in AD patients. Methods: The study will be a randomized, placebo-controlled, double-blind, single-center trial conducted using subjects diagnosed with mild AD by neurologists. Study subjects will be randomly assigned to either a treatment or control group. The treatment group will receive KGT granules for 24 weeks, while the control group will receive placebo granules. AchEI administration will be maintained in both groups during the entirety of the study. Subjects will be assessed using the following exams: the Seoul Neuropsychologic Screening Battery (SNSB) for cognitive function; brain magnetic resonance imaging (MRI) for brain metabolite, neurotransmitter, and cerebral blood flow (CBF) measurements; the Korean version of Quality of Life-Alzheimer's Disease (KQol-AD) for quality of life; the Caregiver-Administered Neuropsychiatric Inventory (CGA-NPI) for neurobehavioral symptoms; blood tests for amyloid and tau proteins and general blood parameters; and electrocardiography (ECG) before and after taking the medication. Discussion: Our findings will provide insight into the feasibility of large-scale trials to consolidate evidence for the efficacy of KGT for dementia treatment. Registration ID in CRIS: KCT0002904 (Clinical Research Information Service of the Republic of Korea).

Abstract

Background: Alzheimer's disease (AD) is a chronic neurodegenerative disease that causes disorientation, mood swings, problems with language, and difficulty remembering recent events. Acetylcholinesterase inhibitors (AchEIs) and memantine have been used to slow the course of the disease, but they can neither modify its progression nor prevent disease onset. Previous studies have suggested that Kami-guibi-tang (KGT) could be beneficial for supporting cognitive function in AD patients, but few clinical trials have been published. This pilot study aimed to evaluate the effect of KGT in improving cognitive function in AD patients. Methods: The study will be a randomized, placebo-controlled, double-blind, single-center trial conducted using subjects diagnosed with mild AD by neurologists. Study subjects will be randomly assigned to either a treatment or control group. The treatment group will receive KGT granules for 24 weeks, while the control group will receive placebo granules. AchEI administration will be maintained in both groups during the entirety of the study. Subjects will be assessed using the following exams: the Seoul Neuropsychologic Screening Battery (SNSB) for cognitive function; brain magnetic resonance imaging (MRI) for brain metabolite, neurotransmitter, and cerebral blood flow (CBF) measurements; the Korean version of Quality of Life-Alzheimer's Disease (KQol-AD) for quality of life; the Caregiver-Administered Neuropsychiatric Inventory (CGA-NPI) for neurobehavioral symptoms; blood tests for amyloid and tau proteins and general blood parameters; and electrocardiography (ECG) before and after taking the medication. Discussion: Our findings will provide insight into the feasibility of large-scale trials to consolidate evidence for the efficacy of KGT for dementia treatment. Registration ID in CRIS: KCT0002904 (Clinical Research Information Service of the Republic of Korea).

참고문헌 (42)

  1. Burns A, "Alzheimer's disease", Bmj, 338, pp.b158~ (2009)
  2. Reisberg B, "Overview of methodologic issues for pharmacologic trials in mild, moderate, and severe Alzheimer's disease", Int Psychogeriatr, 8(2), pp.159~193 (1996)
  3. Karttunen K, "Neuropsychiatric symptoms and quality of life in patients with very mild and mild Alzheimer's disease", Int J Geriatr Psychiatry, 26(5), pp.473~482 (2011)
  4. Wimo A, "The worldwide economic impact of dementia 2010", Alzheimers Dement, 9(1), pp.1~11 (2013)
  5. O'Brien JT, "Clinical practice with anti-dementia drugs:A revised (third) consensus statement from the British Association for Psychopharmacology", J Psychopharmacol, 31(2), pp.147~168 (2017)
  6. 은재순, "귀비탕이 Stress 부하 후 혈중 호르몬 및 비특이적 면역반응에 미치는 영향", 동의생리병리학회지, 18(1), pp.172~178 (2004), 한의병리학회
  7. 전희준, "歸脾湯이 Glutamate에 의한 성상세포의 손상에 미치는 영향", 대한한의학회지, 25(2), pp.184~193 (2004), 대한한의학회
  8. Park IK, "A Study on the Homostatic Effects of Guipitang and Guipitangjiaweifang Extracts in Experimental Animals", The journal of Korean oriental medical ophthalmology & otolaryngology & dermatology, 16(1), pp.63~76 (2003)
  9. 조인수, "歸脾湯 및 歸脾湯加紫河車 추출물 투여로 인한 卵巢摘出 흰쥐의 체중 및 지질대사 변화", 대한본초학회지, 19(3), pp.85~90 (2004), 대한본초학회
  10. 김학재, "스트레스와 에탄올로 유발된 mouse의 위점막 손상에 대한 귀비탕의 예방효과", 대한한의학회지, 24(1), pp.155~168 (2003), 대한한의학회
  11. 정연철, "歸脾湯이 자성 생쥐의 생식능력과 Caspase-3, MAPK , MPG 유전자 발현에 미치는 영향", 대한한방부인과학회지, 20(3), pp.13~34 (2007), 대한한방부인과학회
  12. Oh MS, "The multi-herbal formula Guibi-tang enhances memory and increases cell proliferation in the rat hippocampus", Neuroscience letters, 379(3), pp.205~208 (2005)
  13. Kim SH, "The Radioprotective Effect of Kuei-Pi-Tang as a prescription of Traditional Chinese Medicine in Mice", Journal of the Korean Society of Food Science and Nutrition, 28(3), pp.698~704 (1999)
  14. 김정훈, "EBM 기반구축을 위한 歸脾湯 연구 문헌 분석", 동의신경정신과학회지, 20(3), pp.205~216 (2009), 대한한방신경정신과학회
  15. Ishida K, "Effect of donepezil and kamikihito combination therapy on cognitive function in A lzheimer's disease:R etrospective study", Traditional & Kampo Medicine, 3(2), pp.94~99 (2016)
  16. 馬 込敦, "認知症に対する加味帰脾湯の効果", 漢方 と最新治療, 23(2), pp.135~140 (2014)
  17. Egashira N, "Kamikihi-to, a Kampo medicine, ameliorates impairment of spatial memory in rats", Phytother Res, 21(2), pp.126~129 (2007)
  18. Tohda C, "Kamikihi-to (KKT) rescues axonal and synaptic degeneration associated with memory impairment in a mouse model of Alzheimer's disease, 5XFAD", Int J Neurosci, 121(12), pp.641~648 (2011)
  19. 이주원, "Effect of Guibi-tang on Neuronal Apoptosis and Cognitive Impairment Induced by Beta Amyloid in Mice", 대한한의학회지, 35(4), pp.10~23 (2014), 대한한의학회
  20. Qian YH, "Protective effect of ginsenoside Rb1 on beta-amyloid protein(1-42)-induced neurotoxicity in cortical neurons", Neurol Res, 31(7), pp.663~667 (2009)
  21. Zhang H, "Effects of tenuifolin extracted from radix polygalae on learning and memory:a behavioral and biochemical study on aged and amnesic mice", Phytomedicine, 15(8), pp.587~594 (2008)
  22. Nogami-Hara A, "The Japanese Angelica acutiloba root and yokukansan increase hippocampal acetylcholine level, prevent apoptosis and improve memory in a rat model of repeated cerebral ischemia", J Ethnopharmacol, 214, pp.190~196 (2018)
  23. 조민지, "Comparison of the effect of three licorice varieties on cognitive improvement via an amelioration of neuroinflammation in lipopolysaccharide-induced mice", Nutrition Research and Practice, 12(3), pp.191~198 (2018), 한국영양학회
  24. Folstein MF, "“Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician", J Psychiatr Res, 12(3), pp.189~198 (1975)
  25. "A validity study on the korean mini-mental state examination (K-MMSE) in dementia patients", J Korean Neurol Assoc, 15(2), pp.300~308 (1997)
  26. Kang Y, "Seoul Neuropsychological Screening Battery (SNSB-II)" (2012), Human Brain Research & Consulting Co
  27. Thorgrimsen L, "Whose quality of life is it anyway?The validity and reliability of the Quality of Life-Alzheimer's Disease (QoL-AD) scale", Alzheimer Dis Assoc Disord, 17(4), pp.201~208 (2003)
  28. 신희영, "지역사회 거주 치매환자에서 한국판 삶의 질-알쯔하이머병 척도 개발을 위한 예비연구", 예방의학회지, 39(3), pp.243~248 (2006), 대한예방의학회
  29. Kang SJ, "Caregiver-Administered Neuropsychiatric Inventory (CGA-NPI)", J Geriatr Psychiatry Neurol, 17(1), pp.32~35 (2004)
  30. Harper L, "An algorithmic approach to structural imaging in dementia", J Neurol Neurosurg Psychiatry, 85(6), pp.692~698 (2014)
  31. Citron M, "Alzheimer's disease:strategies for disease modification", Nat Rev Drug Discov, 9(5), pp.387~398 (2010)
  32. Hilal S, "Subcortical Atrophy in Cognitive Impairment and Dementia", J Alzheimers Dis, 48(3), pp.813~823 (2015)
  33. Griffith HR, "Proton magnetic resonance spectroscopy in dementias and mild cognitive impairment", Int Rev Neurobiol, 84, pp.105~131 (2009)
  34. Porges EC, "Frontal Gamma- Aminobutyric Acid Concentrations Are Associated With Cognitive Performance in Older Adults", Biol Psychiatry Cogn Neurosci Neuroimaging, 2(1), pp.38~44 (2017)
  35. Beason-Held LL, "Changes in brain function occur years before the onset of cognitive impairment", J Neurosci, 33(46), pp.18008~18014 (2013)
  36. Chao LL, "ASL perfusion MRI predicts cognitive decline and conversion from MCI to dementia", Alzheimer Dis Assoc Disord, 24(1), pp.19~27 (2010)
  37. Lipczyńska-Łojkowska W, "The effect of rivastigmine on cognitive functions and regional cerebral blood flow in Alzheimer's disease and vascular dementia:follow-up for 2 years", Neurol Neurochir Pol, 38(6), pp.471~481 (2004)
  38. Walsh DM, "Alzheimer's disease and the amyloid β-protein", Prog Mol Biol Transl Sci, 107, pp.101~124 (2012)
  39. Martin L, "Tau protein kinases:involvement in Alzheimer's disease", Ageing Res Rev, 12(1), pp.289~309 (2013)
  40. Meneghini V, "High-mobility group box-1 protein and β-amyloid oligomers promote neuronal differentiation of adult hippocampal neural progenitors via receptor for advanced glycation end products", nuclear factor-κB axis:relevance for Alzheimer's disease, 2013, pp.33(14), 6047~6059
  41. Corder EH, "Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families", Science, 261(5123), pp.921~923 (1993)
  42. Kok E, "Apolipoprotein E-dependent accumulation of Alzheimer disease- related lesions begins in middle age", Ann Neurol, 65(6), pp.650~657 (2009)

관련 논문AI추천

구기지황탕 투여 후 호전된 경도인지장애 환자 1례에 대한 증례보고강석만, 김경순, 박미소, 성현주, 유대원, 유호룡, 정광렬, 채인철대한한방내과학회 · 대한한방내과학회지2021 · 제42권 제5호지역사회 거주 경도인지장애 노인들을 대상으로 시행한한의치료의 보고: 인지기능을 중심으로김윤나, 배준상, 엄윤지, 윤현민, 이경석, 조성훈대한한방신경정신과학회 · 동의신경정신과학회지2019 · 제30권 제3호인지장애 변증평가도구의 신뢰도와 타당도 평가: 임상연구 프로토콜김환, 강위창, 강형원, 서영경, 이지윤, 정인철대한한방신경정신과학회 · 동의신경정신과학회지2018 · 제29권 제4호공진단이 알츠하이머형 치매 환자에게 미치는 영향성우용, 손지형, 이승현, 장하정, 정효창, 한승헤대한한방신경정신과학회 · 동의신경정신과학회지2004 · 제15권 제2호경도인지장애 환자의 장기간 한의약 치료 경과관찰 증례보고 2례강형원, 류영수, 손성은, 이고은, 이나현, 정문주대한한방신경정신과학회 · 동의신경정신과학회지2021 · 제32권 제3호치매의 한약물 치료에 대한 체계적 임상논문 고찰 - 국내문헌을 중심으로 -권용주, 조성훈, 조혜영, 황의완대한한방신경정신과학회 · 동의신경정신과학회지2010 · 제21권 제4호

이 간행물의 다른 논문 (20건)

전신성 활동불능증(Systemic Exertion Intolerance Disease) 진단 기준을 바탕으로 한 만성 피로 증후군(Chronic Fatigue Syndrome) 진단 설문지 개발 및 신뢰도 평가임은진, 손창규, 장은수pp. 293-305고지혈성 급성 췌장염에 대한 대시호탕의 효과 : 체계적 문헌고찰과 메타분석정유진, 김윤정, 박동일pp. 306-325절패모(浙貝母)의 항염 및 진해거담 효과에 대한 실험연구김진후, 이수원, 양원경, 김승형, 박양춘, 유이란pp. 339-349항암화학요법 유발 말초신경병증에 대한 침치료의 효과 : 체계적 문헌고찰 및 메타 분석윤성우, 이지영, 김은혜, 윤지현pp. 350-361중국 및 한국 Database에서의 위식도 역류질환에 대한 반하사심탕의 효과에 대한 최근 10년간의 연구경향홍상훈, 김윤정, 정유진pp. 362-413
원문 보기